Hyderabad, October 19, 2026: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE) has once again earned the Great Place To […]
Sai Life Sciences turns 20!
20 Sep 2019
For a company that started in a small laboratory with two fume hoods, Sai Life Sciences has come a long way in its quest of bringing new medicines to life. Over the past two decades, the company has enabled several innovator pharma and biotech customers discover, develop and manufacture innovative new medicines, and make the lives of patients better.
Today, Sai Life Sciences is among the fastest growing CDMOs in India. Backed by committed investors TPG Capital and HBM Partners, the company is making significant investments in augmenting its capabilities to address the growing demand from innovator companies globally. The next 20 years promise to be even more exciting!
Related News
Hyderabad: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has […]
26 Oct 2026
Sai Life Sciences brought its scientific community together for the Sai Science Symposium 2026, a day dedicated to scientific excellence, […]